In the News

1833 News Items found
Feature
Early menopause "doesn't have to be universally terrifying or terrible," says MSK gynecologic surgeon Jennifer Mueller, above.
5 Myths about Cancer-Related Early Menopause
Learn what to expect from early menopause.
In the Clinic
Scans of Immunotherapy performed on tumors
Case Study Gives Hope for a Clinical Trial Testing Immunotherapy for Aggressive Pituitary Tumors
Summary A woman with an aggressive pituitary tumor responded well to immunotherapy. This successful treatment may lead to a clinical trial testing...
Memorial Sloan Kettering Researchers Build a New Model of Genetically Engineered Immune Cells That May Combat Solid Tumors in the Future
Scientists at Memorial Sloan Kettering Cancer Center (MSK) announced that they have built a new model of genetically engineered immune cells in mice that may allow them to fight solid tumors.
In the Lab
MSK Scientists Build "Armored" CAR T Cells to Smite Solid Tumors
The engineered immune cells secrete powerful drugs as a layer of defense.
Ask the Expert
Five people on the beach during a sunset
Does Vitamin D Reduce the Risk of Getting Cancer?
Two MSK medical oncologists discuss the link between the "sunshine vitamin" and cancer.
In the Lab
kratom leaves and pill
Kratom: What Research Tells Us about This Controversial Supplement for Pain Relief
Learn about kratom, an herbal product that some believe acts as a painkiller and could help those with cancer.
Feature
Woman examining her face for signs of cancer
Five Things to Know If You've Been Diagnosed with Skin Cancer on Your Face
Dermatologic surgeon Erica Lee offers expert advice to people with skin cancer on their nose, eyelid, or another area of their face.
Feature
MSK pathologist Cristina Antonescu in her laboratory
Getting a Correct Diagnosis Is Vital for Treating Sarcoma, a Rare Cancer
MSK's experts in molecular pathology are finding new clues about these tumors.
Announcement
Hematologic oncologist Martin Tallman and nurse practitioner Bernadette Cuello
FDA Approves Ivosidenib (Tibsovo®), a Targeted Drug, for Acute Myeloid Leukemia
The drug provides a new treatment option for people whose cancer has stopped responding to other therapies.
In the Lab
This image shows cancer cells (white) and pericytes (green) clinging to capillaries (red). The blue dots are nuclei.
Scientists Identify Growth Signal for Metastatic Cancer "Seeds"
Targeting this signal with drugs might be one way to stop cancers from spreading.